Getnet Yimer
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Tuberculosis Research and Epidemiology 20
- HIV/AIDS drug development and treatment 13
- Pharmacology 23
- Pharmacogenetics and Drug Metabolism 14
- Drug-Induced Hepatotoxicity and Protection 11
- Co-authors
- Eyasu Makonnen (33 shared papers)Eleni Aklillu (29 shared papers)Abiy Habtewold (21 shared papers)Getachew Aderaye (18 shared papers)Wondwossen Amogne (21 shared papers)Lars Lindquist (10 shared papers)Jürgen Burhenne (12 shared papers)Abebaw Fekadu Wassie (7 shared papers)
- Journals
- PLoS ONE (8 papers)BMC Infectious Diseases (4 papers)Frontiers in Pharmacology (3 papers)Toxicology Letters (3 papers)Frontiers in Public Health (3 papers)
- Partner nations
- EthiopiaUnited StatesSweden
In The Last Decade
Getnet Yimer
96 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 113
- Pharmacology 687
- Infectious Diseases 616
- Virology 46
- Applied Microbiology and Biotechnology 23
- Modeling and Simulation 20
Countries citing papers authored by Getnet Yimer
This map shows the geographic impact of Getnet Yimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Getnet Yimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Getnet Yimer more than expected).
Fields of papers citing papers by Getnet Yimer
This network shows the impact of papers produced by Getnet Yimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Getnet Yimer. The network helps show where Getnet Yimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Getnet Yimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 113 | |
| 2 | 2011 | 107 | |
| 3 | 2013 | 107 | |
| 4 | 2011 | 102 | |
| 5 | 2020 | 84 | |
| 6 | 2014 | 78 | |
| 7 | 2008 | 60 | |
| 8 | 2011 | 56 | |
| 9 | 2014 | 54 | |
| 10 | 2020 | 52 | |
| 11 | 2016 | 44 | |
| 12 | 2012 | 41 | |
| 13 | 2020 | 40 | |
| 14 | 2019 | 35 | |
| 15 | 2017 | 34 | |
| 16 | 2021 | 34 | |
| 17 | 2012 | 32 | |
| 18 | 2019 | 31 | |
| 19 | 2021 | 29 | |
| 20 | 2016 | 28 |
About Getnet Yimer
Getnet Yimer is a scholar working on Infectious Diseases, Pharmacology, Virology, Modeling and Simulation and Public Health, Environmental and Occupational Health, having authored 102 papers that have together received 1.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (20 papers), Pharmacogenetics and Drug Metabolism (14 papers), HIV/AIDS drug development and treatment (13 papers), Drug-Induced Hepatotoxicity and Protection (11 papers), Salmonella and Campylobacter epidemiology (5 papers), Asthma and respiratory diseases (4 papers), Ethics in Clinical Research (4 papers) and COVID-19 epidemiological studies (4 papers). The work is most often cited by research in Pharmacology (687 citations), Infectious Diseases (616 citations), Virology (46 citations), Applied Microbiology and Biotechnology (23 citations) and Modeling and Simulation (20 citations). Getnet Yimer has collaborated with scholars based in Ethiopia, United States and Sweden. Frequent co-authors include Eyasu Makonnen, Eleni Aklillu, Abiy Habtewold, Getachew Aderaye, Wondwossen Amogne, Lars Lindquist, Jürgen Burhenne, Abebaw Fekadu Wassie, Kedir Teji Roba and Tsegahun Manyazewal. Their work appears in journals such as PLoS ONE, BMC Infectious Diseases, Frontiers in Pharmacology, Toxicology Letters and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.